Month: January 2026

Allot Ltd. (NASDAQ: ALLT, TASE: ALLT), a leading global provider of innovative Security-as-a-Service (SECaaS) and network intelligence solutions for communications service providers and enterprises, today announced that its management will be presenting and meeting with investors at the Needham Growth Conference taking place in New York City on Wednesday, January 14, 2026.   Allot’s CEO, Eyal Harari will be presenting live on Wednesday, January 14, 2026 at 11:00a.m. ET. The presentation will also be webcast at that time. To watch the webcast, please visit either a link on Allot’s investor relations website or directly from the following link: https://wsw.com/webcast/needham148/allt/2253699 Management will also be available for one-on-one with institutional investors at Needham that day. For more information about the conference, or to...

Boston, MA, Jan. 05, 2026 (GLOBE NEWSWIRE) — MiniLuxe Holding Corp. (TSXV: MNLX) — MiniLuxe, the pioneer in clean nail care and ethical nail services, announces that on November 20, 2025, its shareholders approved certain amendments to the Company’s equity incentive plan. The amendments converted the plan from a rolling 10% plan to a fixed plan of up to 20% and increased the number of shares available for issuance thereunder to 33,493,526 shares, representing 20% of the aggregate number of subordinate voting shares and proportionate voting shares outstanding as of the date of implementation of the amended plan. Additional details regarding the amended equity incentive plan are set out in the Company’s management information circular dated October 16, 2025, which is available on the Company’s profile on SEDAR+. About MiniLuxeMiniLuxe...

– Obexelimab met the primary endpoint demonstrating a clinically meaningful and highly statistically significant 56% reduction in risk of IgG4-RD flare – – Obexelimab also met and demonstrated statistically significant activity on all four key secondary efficacy endpoints – – Obexelimab was well tolerated and no new safety signals were observed – – Zenas anticipates submitting a Biologics License Application (BLA) to the FDA in the second quarter of 2026 and a Marketing Authorization Application (MAA) to the EMA in the second half of 2026 – – Zenas to host a conference call today, January 5, 2026, at 8:00 a.m. ET – WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global...

STEINHAUSEN, Switzerland, Jan. 05, 2026 (GLOBE NEWSWIRE) — Transocean Ltd. (NYSE: RIG) (“Transocean”) today announced a contract award and an extension, respectively, for two of its drilling rigs. Together, the fixtures represent approximately $168 million of firm backlog. In Brazil, the Deepwater Mykonos was awarded a contract with bp. The estimated 302-day campaign is expected to begin in the third quarter of 2026 and contribute approximately $120 million in backlog, excluding additional services and compensation for mobilization and demobilization. In Norway, three one-well options have been exercised for the Transocean Enabler. The incremental 105 days of work, which is in direct continuation of the rig’s current activity, is expected to contribute approximately $48 million in backlog and commits the Enabler through September...

Program will integrate existing neurocare clinics with HOPE Therapeutics clinics and will engage the already-installed base of 400+ Apollo® Transcranial Magnetic Stimulation (TMS) machines nationwide. Program will unite common treatment protocols and clinical training with neurocare expertise in neuromodulation technology and NRx Pharmaceuticals neuroplastic drug development program. Pilot program with a state first-responder agency has demonstrated high rates of success in combining TMS, neuroplastic drug treatment, hyperbaric oxygen, and psychotherapy to achieve remission from PTSD and Depression in First Responders. neurocare and NRx look forward to offering an integrated treatment program to patients and payers within driving distance of any American home by year-end 2026.WILMINGTON, Del. and MUNICH, Jan. 05, 2026 (GLOBE NEWSWIRE)...

MONACO, Jan. 05, 2026 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE:STNG) (“Scorpio Tankers,” or the “Company”) announced today that it has entered into agreements to time charter-out the 2015 built LR2 product tankers, STI Rose and STI Alexis. The term of each agreement is five years at a rate of $29,000 per vessel per day. These time charters are expected to commence in the first quarter of 2026. About Scorpio Tankers Inc. Scorpio Tankers Inc. is a provider of marine transportation of petroleum products worldwide. Scorpio Tankers Inc. currently owns or lease finances 93 product tankers (37 LR2 tankers, 42 MR tankers and 14 Handymax tankers) with an average age of 9.8 years. The Company has entered into agreements to sell three LR2 product tankers which are expected to close in the first quarter of 2026. The Company has also reached...

Date: Friday, January 30, 2026Time: 10:00 a.m. (Eastern Time) BROOKFIELD, NEWS, Jan. 05, 2026 (GLOBE NEWSWIRE) — Brookfield Business Partners will host its Fourth Quarter 2025 Conference Call & Webcast on Friday, January 30, 2026 at 10:00 a.m. (ET) to discuss results and current business initiatives. Results will be released on Friday, January 30, 2026 prior to 8:00 a.m. (ET) and will be available following the release on our website at https://bbu.brookfield.com. Participants can join by conference call or webcast: Conference CallPlease pre-register: BBU2025Q4ConferenceCall Upon registering, you will be emailed a dial-in number and unique PIN. This process will bypass the operator and avoid the queue.WebcastPlease join and register by webcast: BBU2025Q4Webcast A replay of the webcast will be available on our website.Brookfield...